Tarini Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 02-07-2024
- Paid Up Capital ₹ 0.50 M
as on 02-07-2024
- Company Age 12 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2023)
- Ebitda
- Net Worth
- Total Assets -9.06%
(FY 2023)
About Tarini Lifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Anilbhai Mehta, Vakamulla Naidu, and Vakamulla Shekhar serve as directors at the Company.
- CIN/LLPIN
U85100DL2012PLC233368
- Company No.
233368
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
23 Mar 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Tarini Lifesciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anilbhai Mehta  | Director | 23-Mar-2012 | Current |
| Vakamulla Naidu | Director | 23-Mar-2012 | Current |
| Vakamulla Shekhar | Director | 23-Mar-2012 | Current |
Financial Performance of Tarini Lifesciences.
Tarini Lifesciences Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Tarini Lifesciences?
In 2023, Tarini Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Tarini International LimitedActive 25 years 11 monthsVakamulla Naidu and Vakamulla Shekhar are mutual person
- Tarini Sugars And Distillaries LimitedActive 18 years 5 months
Vakamulla Naidu and Vakamulla Shekhar are mutual person
- Tarini Infrastructure LimitedActive 20 years 1 month
Vakamulla Naidu and Vakamulla Shekhar are mutual person
- Venture Infrastructure LimitedActive 21 years 4 months
Vakamulla Naidu and Vakamulla Shekhar are mutual person
- Tarini Wilderness Innovations Private LimitedActive 13 years 6 months
Vakamulla Naidu and Vakamulla Shekhar are mutual person
- Tarini Humanitarian Demining & Rehabilitation WorksActive 19 years 9 months
Vakamulla Naidu and Vakamulla Shekhar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Tarini Lifesciences?
Unlock and access historical data on people associated with Tarini Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tarini Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tarini Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
